S&P 500 7,591.70 −0.58%
Nasdaq 26,081.73 −0.65%
S&P/TSX 35,506.28 −1.11%
Apple 326.57 +3.56%
Nvidia 218.36 −2.37%
Microsoft 492.44 +0.16%
Shopify 175.14 +0.01%
Royal Bank 284.98 −0.21%
CAD/USD 0.7226 −0.25%
CLOSED · 00:25 ET
Market ClerkRecap
Fri Sep 11 · markets closed4 signals on Sep 10223 insider buys this week · $359.5MCIRO short report next: Sep 14The week ahead
PD
INSIDER · PTGX · Protagonist Therapeutics, Inc · PRESIDENT AND CEO

PATEL DINESH V PH D

Every open-market transaction filed under this name, Sep 8 to Sep 10.

Filings
3
0 buys · 3 sells
Bought
open market, at cost
Sold
$18.2M
includes scheduled sales
Buys since
no current price on file

Filings

SEC FORM 4 · OPEN MARKET
TradedTickerCompanyRoleTypeSharesPriceValueSince
Sep 10PTGXProtagonist Therapeutics, IncPresident and CEOSell7,278$144.10$1M
Sep 9PTGXProtagonist Therapeutics, IncPresident and CEOSell63,548$146.18$9.3M
Sep 8PTGXProtagonist Therapeutics, IncPresident and CEOSell54,174$145.87$7.9M

"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.